Skip to content

Clinical trials

Completed Cardiovascular Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Status: Completed Country / region: China Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20041
20052
20061
20083
20096
20107
20114
20126
20132
20144
20154
20178
20185
20196
20204
20214
20226
202310
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed89

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medtronic Vascular4
The George Institute for Global Health, China4
China National Center for Cardiovascular Diseases3
GlaxoSmithKline3
The George Institute3
AstraZeneca2
Boston Scientific Corporation2
Chinese PLA General Hospital2
Chinese University of Hong Kong2
Nanfang Hospital, Southern Medical University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases89
Coronary Artery Disease14
Heart Diseases12
Myocardial Ischemia12
Arteriosclerosis11
Coronary Disease10
Hypertension10
Vascular Diseases10
Stroke9
Cerebrovascular Disorders7

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.